ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 138 filers reported holding ARRAY BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $264,000 | -48.9% | 5,700 | -73.1% | 0.02% | -50.0% |
| Q1 2019 | $517,000 | +28.6% | 21,200 | -24.8% | 0.03% | +18.5% |
| Q4 2018 | $402,000 | -6.3% | 28,200 | 0.0% | 0.03% | +8.0% |
| Q3 2018 | $429,000 | -9.3% | 28,200 | 0.0% | 0.02% | -10.7% |
| Q2 2018 | $473,000 | +2.8% | 28,200 | 0.0% | 0.03% | -3.4% |
| Q1 2018 | $460,000 | +27.4% | 28,200 | 0.0% | 0.03% | +26.1% |
| Q4 2017 | $361,000 | -64.8% | 28,200 | -87.5% | 0.02% | -85.6% |
| Q3 2015 | $1,026,000 | -36.7% | 225,000 | 0.0% | 0.16% | -36.3% |
| Q2 2015 | $1,622,000 | -2.2% | 225,000 | 0.0% | 0.25% | +9.1% |
| Q1 2015 | $1,658,000 | +233.6% | 225,000 | +114.3% | 0.23% | +228.6% |
| Q4 2014 | $497,000 | +32.5% | 105,000 | 0.0% | 0.07% | +20.7% |
| Q3 2014 | $375,000 | -21.7% | 105,000 | 0.0% | 0.06% | -21.6% |
| Q2 2014 | $479,000 | -3.0% | 105,000 | 0.0% | 0.07% | -5.1% |
| Q1 2014 | $494,000 | -6.1% | 105,000 | 0.0% | 0.08% | -8.2% |
| Q4 2013 | $526,000 | -62.4% | 105,000 | -53.3% | 0.08% | -68.0% |
| Q3 2013 | $1,400,000 | -5.1% | 225,000 | -30.8% | 0.27% | -1.1% |
| Q2 2013 | $1,476,000 | – | 325,000 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 15,978,580 | $268,121,000 | 9.11% |
| BVF INC/IL | 4,672,195 | $78,399,000 | 7.65% |
| First Light Asset Management, LLC | 2,391,575 | $40,131,000 | 6.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 694,500 | $11,647,000 | 4.47% |
| Copernicus Capital Management, LLC | 286,797 | $4,812,000 | 3.49% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 225,511 | $3,784,000 | 3.00% |
| SECTORAL ASSET MANAGEMENT INC | 1,566,477 | $26,285,000 | 2.94% |
| X-Square Capital, LLC | 173,802 | $2,917,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,618,654 | $43,941,000 | 1.48% |
| Birchview Capital, LP | 128,000 | $2,148,000 | 1.46% |